NCT02212197 - Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

March 31, 2016

Conditions

Prostate Cancer

Interventions

DRUG

leuprolide acetate FluidCrystal® injection depot

DRUG

leuprolide acetate

Trial Locations (7)

Docrates Cancer Center, Helsinki

University Hospital of Helsinki, Department of Urology, Helsinki

Tampere University Hospital, Department of Urology, Tampere

University Hospital of Turku, Department of Urology, Turku

Semmelweis University Hospital Department of Urology, Budapest

Szent Imre Teaching Hospital, Budapest

University of Debrecen, Medical Health Sciences Center, Department of Urology, Debrecen